FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 11:41:22 09/05/2024 am IST | ||
| 0.69 EUR | +1.47% |
|
| Current month | +9.52% | ||
| 1 month | +32.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/24/09 | 0.69 | +1.47% | 0 |
| 08/24/08 | 0.68 | -5.56% | 0 |
| 07/24/07 | 0.72 | +7.46% | 0 |
| 06/24/06 | 0.67 | +11.67% | 0 |
| 03/24/03 | 0.6 | -9.09% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 09, 2024 at 11:41 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SH2L91 |
| ISIN | DE000SH2L914 |
| Date issued | 09/02/2022 |
| Strike | 221.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.09 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.03 € |
|---|---|
| Lowest since issue | 0.38 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
219.7
USD
Average target price
285.9
USD
Spread / Average Target
+30.13%
- Stock Market
- Certificates
- Certificat